US$ 27.36
compound pharmacy ghk cu GHK-Cu / Hyaluronic Acid - Gel GHK-Cu Peptide (100mg) for Research
Description
K.TannouryC
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: patient-focused outcome results from the randomised phase III REACH study

Verify the medication comes from refrigerated storage

In studies using obese murine models, AOD9604 administration was associated with increased lipolysis that coincided with elevated 3-AR mRNA expression, supporting the hypothesis that the peptide sensitizes fat cells to lipolytic signaling rather than simply forcing fat breakdown through a separate pathway
All compounds referenced are intended for laboratory and research use only
